View more Leadership Team
Dr Leonor Cerdaal Berich
WG1 Leader
Area of Research
NON INVASIVE BIOMARKER DISCOVERY (Theme-1) As mentioned above, the diagnosis of brain tumours is currently based on neuro-imaging and tissue biopsy. Brain biopsy is invasive and is associated with varied risks depending on the size and accessibility of the target. Non-invasive biomarkers could provide a complement and early solution to monitoring brain tumours. This theme aims to discover sensitive and specific brain cancer biomarkers in liquid biopsy as well as radiomics biomarkers.
Biography
It is estimated that 3.24 million new cancer cases and 1.66 million cancer deaths will be registered across Europe in 2024, and 40,800 of these deaths are from brain and central nervous system (CNS) cancers. Despite extensive efforts in molecular biology research, advances in biomedical engineering, artificial intelligence (AI), and big data science, brain tumours remain among the deadliest forms of cancer…
Projects & Grants
Non Invasive Biomarker Discovery